Other hormones that modulate hair growth include estrogens,
thyroid hormones, glucocorticoids, retinoids, prolactin, and
growth hormone.1
Minoxidil has been used for patients with severe hypertension
and was incidentally observed to result in hair growth.
The mechanism by which minoxidil induces hair growth is not
fully elucidated, but may be related to its action on opening
of the adenosine triphosphate (ATP) sensitive potassium channel
(K[ATP] channel). K(ATP) channel opening in dermal papilla
cells at the base of the follicle is thought to play a role in stimulating
hair growth.15 As a vasodilator, it may promote more
oxygen, blood, and nutrients to the proliferating dermal papilla
cells. Other studies have shown that minoxidil stimulates
the production of growth factors such as vascular endothelial
growth factor in cultured dermal papilla cells, and that these
growth factors might stimulate hair growth.16 It has also been
shown that minoxidil promotes the survival of human dermal
papilla cells, thereby prolonging anagen, through proliferative
and anti-apoptotic effects.17
Prostaglandin analogues, such as bimatoprost, have been
shown to induce eyelash growth, although the mechanism
is unclear. It is suggested that hypertrichosis is probably a
result of the induction of the anagen phase in the telogen
phase follicles of the eyelashes and prolonging the anagen
phase.18 Anecdotal cases describe significant eyebrow hair
growth after use of topical prostaglandin analogues for eyebrow
hypotrichosis.19
Other Hair Follicle Disorders
In contrast to AGA, hirsutism and hypertrichosis result from a
prolonged anagen stage with an abnormal enlargement of hair
follicles; small, fine vellus hairs transform into large, terminal
hairs. This can be caused by medications or hormonal factors
(eg, dysfunction in the adrenal glands or ovaries resulting in
hyperandrogenism).
Anagen effluvium is caused by the cessation of anagen, often
due to antineoplastic/chemotherapeutic drugs, which disrupt
the rapidly proliferating bulb matrix cells. As a result, the hair
shaft becomes narrower, with subsequent breakage and loss
of the hair. Because the stem cells of the hair follicles are typically
spared, a new hair bulb may be regenerated once the medication is stopped. Hair loss usually begins 1 to 2 weeks
after chemotherapy is started and is most noticeable by 1 to 2
months.20 The scalp hair is usually most affected, but all body
hair, including eyelashes and eyebrows, can be affected.21
Inflammatory alopecias (such as lichen planopilaris and discoid
lupus erythematosus) can lead to permanent scarring
hair loss, whereas others (such as alopecia areata and telogen
effluvium) are nonscarring and potentially reversible.
In scarring alopecias, the inflammation usually involves the
superficial portion of the follicle, including the bulge area, resulting
in permanent destruction of the stem cells necessary
for the regeneration of the follicle. In contrast, the acute follicular
inflammation in alopecia areata targets the hair bulb
in the subcutaneous fat, resulting in disruption of the anagen
stage. Because the bulge area is spared, the hair follicle has
the potential to generate a new hair bulb and hair shaft once
the inflammation has resolved.
Hair disorders associated with rare congenital hair defects,
such as Netherton’s syndrome and ectodermal dysplasias, are
caused by mutations in keratins or other structural proteins.
Netherton’s syndrome is an autosomal recessive disease
caused by mutations in serine protease inhibitor Kazal-type
5, encoding the serine protease inhibitor lympho-epithelial
Kazal-type-related inhibitor. It presents with an atopic diathesis,
allergic reactions, and icthyosiform dermatitis. A clue
to diagnosis is the examination of eyebrow hairs, which will
characteristically show trichorrhexis invaginata, in which the
distal portion of the shaft is invaginated into the proximal portion.
22 Eyebrows may be the sole site of involvement in many
patients with Netherton’s syndrome, and the findings more
prominent than in the scalp.22
CONCLUSION
In summary, eyebrow hair serves many important biologic functions,
including sensory transmission and protection from the
elements, as well as playing an important role in cosmesis and
expression. The hair follicle originates from complex mesenchymal-
epithelial interactions during embryogenesis. Similar
molecular mechanisms underlie hair follicle cycling during one’s
lifetime. Knowledge of the hair follicle structure and cycle is key
to understanding the pathogenesis of the different types of alopecia,
as well as developing targeted therapies for hair loss.
DISCLOSURES
Jennifer V. Nguyen MD has no conflicts of interest to disclose.
REFERENCES
- Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med. 1999;341(7):491-497.
- Langbein L, Schweizer J. Keratins of the human hair follicle. Int Rev Cytol. 2005;243:1-78.
- Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol. 2006;126(7):1459-1468